周一,TD Cowen将CVS Health (NYSE:CVS)的股票目标价从73.00美元上调至80.00美元,同时维持买入评级。此次上调反映了对该公司未来的积极展望,特别是对2025年这个关键年份的看好。TD Cowen的分析师将CVS列为2025年的首选股票,虽然承认存在较高风险,但强调了潜在的可观回报。
CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...